Federal Register: FDA Finds Isturisa Was Not Withdrawn for Safety, Clearing Path for Generics
September 30, 2026
September 30, 2026
WASHINGTON, Sept. 30 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following action in the Federal Register.
* * *
Determination That ISTURISA (Osilodrostat) Tablets, 10 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA) has determined that ISTURISA tablets, 10 milligrams (mg), was not withdrawn from sale for reasons of safety or effectiv . . .
* * *
Determination That ISTURISA (Osilodrostat) Tablets, 10 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The Food and Drug Administration (FDA) has determined that ISTURISA tablets, 10 milligrams (mg), was not withdrawn from sale for reasons of safety or effectiv . . .